Wright Don - 14 Jun 2023 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Reporting relationship
Director
Issuer ticker
ISCO
Reported as of
14 Jun 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Jun 2023, 17:23:47 UTC
Prior SEC filing
10 Jun 2022
Next SEC filing
13 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Russell Kern, Attorney-in-Fact

Key filing fact

Wright Don filed Form 4 for International Stem Cell CORP (ISCO) on 16 Jun 2023.

Key facts

  • This page summarizes Wright Don's Form 4 filing for International Stem Cell CORP (ISCO).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2023, 17:23.

Change

  • Previous filing in this sequence was filed on 10 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISCO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+30,000
Change %
Price
$0.000000
Shares after
30,000
Date
14 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$0.1400
Footnotes
F1
ISCO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+445,205
Change %
Price
$0.000000
Shares after
445,205
Date
14 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
445,205
Exercise price
$0.1400
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Options vest fully at the earlier of (i) 06/14/2024 or (ii) the date of the 2024 Annual Meeting of Stockholders.

Footnote F2

Options vest in four equal quarterly increments, beginning 09/14/2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .